Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ628630,50,16
KB768771-0,77
PKN78,478,48-3,54
Msft-0,79
Nokia4,3364,3515-0,90
IBM-1,70
Daimler AG76,9877,01-3,00
PFE-1,70
19.06.2021 1:36:27
Indexy online
AD Index online
select
AD Index online
 

  • 18.06.2021
Tecan Group (TECN.S, Swiss Exchange)
Závěr k 18.6.2021 Změna (%) Změna (CHF) Objem obchodů (CHF)
442,60 0,59 2,60 2 730 938
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 19.06.2021
Popis společnosti
Obecné informace
Název společnostiTecan Group AG
TickerTECN
Kmenové akcie:Ordinary Shares
RICTECN.S
ISINCH0012100191
Poslední známé roční výsledky31.12.2020
Poslední známé čtvrtletní výsledky31.12.2020
Počet zaměstnanců k 31.12.2020 2 050
Akcie v oběhu k 02.06.2021 12 016 175
MěnaCHF
Kontaktní informace
UliceSeestrasse 103
MěstoMAENNEDORF
PSČ8708
ZeměSwitzerland
Kontatní osobaMartin Braendle
Funkce kontaktní osobySenior Vice President, Corporate Communications & Investor Relations
Telefon41 449 228 111
Fax41449228112
Kontatní telefon41 449 228 430

Business Summary: Tecan Group AG is a Switzerland-based company engaged in the development, production and distribution of advanced automation and detection solutions for the life science laboratories. Its product portfolio is diversified into several product groups. The Liquid Handling & Robotics group encompasses laboratory technologies for safety, among others. The Reader & Washer product group covers micro plate instruments. The Microarray Products group includes microarray scanner and automated hybridization station. The HP D300 Digital Dispenser and Sample Management product groups cover systems for automated management of sample libraries. The Components group covers the supply services of products for laboratory automation instruments. The OEM (original equipment manufacturing) product group covers platform-based systems, systems from scratch and Cavro OEM Components. The Company also offers packaged software and consumables through Software and Consumables product groups, respectively.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2020, TecanGroup AG revenues increased 15% to SF730.9M. Net incomeincreased 42% to SF103.7M. Revenues reflect Life SciencesBusiness segment increase of 13% to SF408.8M, PartneringBusiness segment increase of 17% to SF322.1M, Europe(excluding Switzerland) segment increase of 8% to SF272.6M,Asia segment increase of 18% to SF121.7M, Others segmentincrease of 40% to SF15M.
Odvětvová klasifikace
TRBC2009Office Equipment
TRBC2012Scientific & Precision Equipment
RBSS2004Biotechnology
MGINDUSTRYScientific & Technical Instr.
MGSECTORTechnology
NAICS2007Analytical Laboratory Instrument Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
NAICS1997Analytical Laboratory Instrument Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Research and Development in the Physical, Engineering, and Life Sciences
SICAnalytical Instruments
SICSurgical And Medical Instruments
SICCommercial Physical Research



  • Poslední aktualizace: 19.06.2021
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Member of the Management BoardAchim Von Leoprechting5201.04.2019
Chief Financial Officer, Member of the Management BoardTania Micki5017.02.202017.02.2020
Chief People Officer, Member of the Management BoardIngrid Purgstaller41
Executive Vice President, Chief Technology Officer, Head Research and Development, Member of the Management BoardWael Yared5801.01.2019
Executive Vice President General Counsel and Secretary of the Board of Directors, Member of the Management BoardAndreas Wilhelm5101.01.2004
Executive Vice President, Head of the Partnering Business division, Member of the Management BoardRalf Griebel49
Executive Vice President, Head of the Division Development and Operations, Member of the Management BoardUlrich Kanter57
Executive Vice President, Head of the Life Sciences Business Division, Member of the Management BoardKlaus Lun48
Executive Vice President, Head of Corporate Development, Member of the Management BoardErik Norstrom47